Passage Bio
@Passage_Bio
Followers
798
Following
160
Media
293
Statuses
673
World-class genetic medicines company that’s changing the future of CNS disease. $PASG #GeneTherapy #FTDementia
Philadelphia, PA
Joined June 2019
We announced our Q3 2025 financial results and highlighted meaningful progress as we advance our upliFT-D clinical trial evaluating our investigational therapy in frontotemporal dementia. Read the full update: https://t.co/GT9q4o46Be
0
0
0
#Investors: We are excited to participate in the Guggenheim 2nd Annual Healthcare Innovation Conference and look forward to connecting and sharing our progress in advancing genetic medicines for neurodegenerative diseases. Learn more: https://t.co/ZT3cZtKVAS
#InvestorRelations
0
0
0
At the 32nd Annual @ESGCT Congress, our Chief Scientific Officer shared the latest data from our frontotemporal dementia candidate program, sharing insights on advancing gene therapy for neurodegenerative diseases. View our poster presentation here: https://t.co/9FszlnqpWz
#ESGCT
0
0
1
We’re heading to New York for @ChardanCM's 9th Annual Genetic Medicines Conference! Passage Bio will take part in the panel, “Gene Therapy for Neurodegenerative Diseases – Are We There Yet?” Look for us there to learn about our latest progress: https://t.co/I4n2xeLRP6
1
0
1
Passage Bio is at the 2025 FTD Research Roundtable, working with peers and experts to pave the way for more effective clinical trials and better outcomes for families affected by FTD. Learn more: https://t.co/ximJYdrytk
#FTD
#GeneTherapy
#ClinicalResearch
#MedEd
0
0
0
ICYMI: Passage Bio CEO, Will Chou, M.D., presented at the @HCWCO Annual Global Investment Conference! He shared our latest advances in genetic medicines for neurodegenerative diseases. Watch the full webcast: https://t.co/A6FEEp0tzI
#GeneTherapy
#HCWainwright
0
0
0
Passage Bio is attending the @HCWCO 27th Annual Global Investment Conference in NYC where we will share updates on our work in genetic medicines for neurodegenerative diseases. Look for us there! https://t.co/nLMQqFgv16
#HCWainwright
#GeneTherapy
#InvestorRelations
0
0
0
Our CEO, Will Chou, MD, joins @_CellandGene: The Podcast to discuss the potential of gene therapy in frontotemporal dementia (FTD) and share data from our clinical program presented at #AAIC2025. Listen here: https://t.co/TjE5Mr90ho
#GeneTherapy
#FTD
#Neurodegeneration
cellandgene.com
In this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Will Chou, M.D., CEO of Passage Bio about the promise and challenges of developing gene therapies for frontotemporal dementia...
0
0
0
Today, we shared our Q2 2025 #financialresults along with important #business updates. Check out our recent progress with the upliFT-D clinical trial and what’s ahead here: https://t.co/ucT1YUUuXw $PASG
0
0
0
Our team just wrapped #AAIC2025! Thank you to everyone who stopped by our poster to learn more about our gene therapy program. #GeneTherapy
#NeurodegenerativeDiseases
#MedEd
0
0
1
We’re presenting interim data from our Phase 1/2 upliFT-D trial for FTD with GRN mutations at #AAIC2025 — the largest global dementia research conference. Excited to connect and accelerate progress with the community. #GeneticMedicines
#ClinicalTrials
#MedEd
0
0
3
We’re deeply saddened by the passing of our colleague and friend, Chip Cale, Passage Bio’s General Counsel. Chip’s authenticity, spirit, and dedication left a lasting impact on all who knew him. Our thoughts are with his family and loved ones.
paganofuneralhome.com
Edgar "Chip" Barclay Cale III of Wayne, Pennsylvania, passed away peacefully at the age of 61 on June 16, 2025. He was born in Drexel Hill, Pennsylvania to E. Barclay Cale Jr. (Marilyn Chambers) and...
0
0
0
#NEWS: Today we reported updated interim data from the ongoing Phase 1/2 upliFT-D #clinicaltrial evaluating our potential treatment for frontotemporal #dementia (#FTD) with granulin (GRN) mutations. Read about the data and program updates here: https://t.co/B5Jl8Vn4pe
#meded
0
0
1
We observe #Juneteenth as a company holiday giving our team time to reflect, learn, and support their communities. At Passage Bio, inclusion, equity, and respect are core to who we are. Today and every day, we stand for justice.
0
0
0
Our Patient Advocacy team hosted a reTHINK with Dementia workshop in partnership with @4theirthoughts. The session gave participants a deeper, more personal understanding of what it’s like to live with #dementia, helping to build empathy, connection, and better care.
0
0
1
We were proud to share new process development data for our gene therapy candidate at the @ASGCTherapy Annual Meeting. Our internally developed, suspension-based manufacturing process showed substantial gains in productivity, purity, and full capsids: https://t.co/BZzMrd5zJm
0
0
0
On #MemorialDay, we pause to remember the heroes who gave their lives in service to our nation.
0
0
0
This morning, we announced our first quarter 2025 #financialresults and recent #business highlights. Learn more about our achievements and upcoming milestones here: https://t.co/g3dY84Aumb $PASG
0
0
0
This #HDAwarenessMonth, we remain driven by a bold mission: to change the trajectory of #Huntingtonsdisease and other neurodegenerative conditions with the power of genetic medicine. #GeneticMedicine #HD
0
0
0